Exploring how pharmacogenomics and personalized medicine are revolutionizing treatment approaches for glioblastoma multiforme (GBM), the most aggressive primary brain tumor.
Discover how mutant IDH1-driven cancers depend on their wild-type counterpart, revealing a paradoxical Achilles' heel in glioblastoma treatment.
Explore how human embryonic stem cells are revolutionizing brain cancer research, enabling accurate tumor modeling and personalized treatment development.